Basilea Pharmaceutica AG
BPMUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $579,771 | $418,905 | $569,988 | $436,654 |
| - Cash | $120,700 | $59,900 | $84,700 | $53,700 |
| + Debt | $111,671 | $128,606 | $187,138 | $218,955 |
| Enterprise Value | $570,742 | $487,611 | $672,426 | $601,909 |
| Revenue | $208,543 | $157,634 | $147,765 | $148,122 |
| % Growth | 32.3% | 6.7% | -0.2% | – |
| Gross Profit | $169,862 | $130,840 | $123,162 | $124,050 |
| % Margin | 81.5% | 83% | 83.3% | 83.7% |
| EBITDA | $66,336 | $23,240 | $21,710 | $3,562 |
| % Margin | 31.8% | 14.7% | 14.7% | 2.4% |
| Net Income | $77,593 | $10,451 | $12,147 | -$6,831 |
| % Margin | 37.2% | 6.6% | 8.2% | -4.6% |
| EPS Diluted | 5.83 | 0.86 | 1.02 | -0.58 |
| % Growth | 577.9% | -15.7% | 275.9% | – |
| Operating Cash Flow | $74,363 | $14,245 | $7,056 | -$32,020 |
| Capital Expenditures | -$1,792 | -$1,034 | -$3,303 | -$860 |
| Free Cash Flow | $72,571 | $13,211 | $3,753 | -$32,880 |